Capital Research Global Investors’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,404,294	Closed	-$139M	–	442
2021 Q3	$139M	Sell	5,404,294 -6	-0%	-$142	0.03%	281
2021 Q2	$141M	Sell	5,404,300 -7,259,713	-57%	-$207M	0.03%	272
2021 Q1	$447M	Buy	12,664,013 +23,675	+0.2%	+$799K	0.11%	169
2020 Q4	$319M	Buy	12,640,338 +22,346	+0.2%	+$728K	0.08%	195
2020 Q3	$476M	Buy	12,617,992 +609,223	+5%	+$23M	0.14%	141
2020 Q2	$514M	Buy	12,008,769 +3,036,198	+34%	+$110M	0.16%	132
2020 Q1	$174M	Buy	8,972,571 +2,429,893	+37%	+$57.9M	0.07%	195
2019 Q4	$170M	Buy	6,542,678 +1,268,228	+24%	+$34.9M	0.05%	223
2019 Q3	$144M	Buy	5,274,450 +24	+0%	+$684	0.05%	238
2019 Q2	$142M	Buy	5,274,426 +1,923,894	+57%	+$53.6M	0.05%	239
2019 Q1	$95.7M	Buy	3,350,532 +843,344	+34%	+$24.5M	0.03%	266
2018 Q4	$62.6M	Buy	+2,507,188	New	+$66.6M	0.02%	294